This later developed into chest tightness
4 CTFPHC Working Group Members Task Force Members: Brett Thombs (Chair) Kevin Pottie Patricia Parkin Marcello Tonelli Public Health Agency: Alejandra Jaramillo Garcia* Dana Reid* Kate Morisette* Evidence Review and Synthesis Centre: Leslea Peirson* Muhammad Usman Ali* Donna Fitzpatrick-Lewis* Meghan Kenny* Parminder Raina* Sharon Peck-Reid* Maureen Rice* Diana Sherifali* Rachel Warren * 6 *non-voting member Background Tobacco kills up to half of its users globally The global tobacco epidemic is one of the largest public health threats Tobacco users who die prematurely: Deprive their families of income Raise the cost of health care Hinder economic development Annual cost to Canadian society was estimated at $17 billion in 2002 Among Canadian youth, 18% have tried cigarettes Increasing from 3% of 6th graders up to 36% of 12th graders 8 A person who starts smoking as a child or youth is less likely to quit later in life than someone who starts later Methods of the CTFPHC Independent panel of: Clinicians and methodologists Expertise in prevention, primary care, literature synthesis, and critical appraisal Application of evidence to practice and policy Tobacco Working Group 4 CTFPHC members Establish research questions and analytical framework 11 Methods of the CTFPHC Evidence Review and Synthesis Centre (ERSC) Undertakes a systematic review of the literature based on the analytical framework Prepares a systematic review of the evidence with GRADE tables Participates in working group and task force meetings Obtains expert opinions 12 Research Questions The systematic review for tobacco prevention and treatment included: (2) key research questions on prevention with (2) sub questions (3) key questions on treatment with (2) sub questions (2) contextual questions Based on the search done for the 2012 United States Preventive Services Task Force (USPSTF) review on the same topic For more detailed information, please access the systematic review www.canadiantaskforce.ca 14 Analytical Framework: Prevention & Treatment 15 incidence of tobacco smoking KQ1 KQ2 prevalence of adult tobacco smoking interventions to prevent tobacco smoking school-aged children and youth (5-18 years) who have never smoked tobacco or are not currently smoking tobacco Harms of treatment incidence of stopping tobacco smoking KQ3 KQ5 KQ4 prevalence of adult tobacco smoking interventions to treat tobacco smoking school-aged children and youth (5-18 years) who currently smoke tobacco Prevention Treatment Research Questions Prevention KQ1 Are behaviourally-based interventions that are designed to prevent tobacco smoking effective in preventing children/youth from trying or taking up tobacco smoking
ZYN Nicotine Pouches Coffee Bold, rich, and aromatic, this flavor is a hit among coffee lovers who want their nicotine fix paired with the taste of their favorite beverage
Finally, despite the reported roles of distinct ILC subsets in various diseases 14 , little is known about airway ILCs in smokers, let alone about these cells in smokers with asthma, on whom there are no published data
